MAG
AMED

Millrace Asset Group’s Amedisys AMED Stock Holding History

Millrace Asset Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,637
Closed -$487K – 53
2022
Q2 		$487K Sell
4,637
-10,014
-68% -$1.28M 0.46% 55
2022
Q1 		$2.52M Buy
+14,651
New +$2.19M 1.83% 18
2020
Q2 		– Sell
-7,470
Closed -$1.37M – 73
2020
Q1 		$1.37M Buy
7,470
+320
+4% +$56.9K 2.07% 15
2019
Q4 		$1.19M Sell
7,150
-5,300
-43% -$788K 1.3% 44
2019
Q3 		$1.63M Buy
+12,450
New +$1.62M 1.91% 19
2017
Q3 		– Sell
-25,900
Closed -$1.63M – 65
2017
Q2 		$1.63M Sell
25,900
-8,600
-25% -$501K 1.54% 31
2017
Q1 		$1.76M Buy
+34,500
New +$1.65M 1.79% 30

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Millrace Asset Group's AMED Position: Q3 2022 in Review

Millrace Asset Group sold out of Amedisys (AMED) in Q3 2022, closing a stake of 4,637 shares — an estimated $487K sold.

Millrace Asset Group first reported a position in AMED in Q1 2017 and held it in 7 quarters. The position peaked at $2.52M in Q1 2022. 287 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Millrace Asset Group reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Millrace Asset Group sold 4,637 Amedisys shares in Q3 2022, an estimated $487K.
  • Millrace Asset Group first reported a position in Amedisys in Q1 2017 and held it in 7 quarters.
  • Millrace Asset Group's Amedisys position peaked at $2.52M in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Millrace Asset Group's 13F filing for Q3 2022, filed 31 Oct 2022.